'Women of Bio21' Profiles - Yan Hong Tan

Meet Yan Hong Tan, Melbourne Protein Characterisation & ACRF Facility for Innovative Cancer Drug Discovery, acting Centre Manager

Australian Synchrotron Roadshow stops @Bio21Institute - 1.30 - 5pm, Tuesday, 29 October

Tuesday, 29 October, 2019 - 13:30 to 17:00

The University and the Australian Synchrotron are coordinating a Roadshow event to showcase the capabilities of the Synchrotron beamlines.

Bio21 'Big Picture': Addressing Chronic Pain: A Major Health Problem in Australia and Globally - 3pm, 4 November

Monday, 4 November, 2019 - 15:00 to 16:00

Neuropathic pain is a large unmet medical need. Em Prof Smith tells about how a successful trial may see her work enter the clinic.

Getting revegetation right with genetics

Genetic variation is critical to allow populations to adapt to current and future environmental stresses. Read Pursuit piece by Bio21's Ary Hoffmann...

Academia and industry join forces against malaria

Professor Leann Tilley and Dr Stanley Xie from the Bio21 Institute are working with experts from the Japanese company, Takeda Pharmaceuticals, and Swiss-based foundation, Medicines for Malaria Venture (MMV), in a double-pronged effort to develop new antimalarial drugs.  

$14m invested to create vaccine for debilitating periodontal gum disease

Melbourne Dental School Head of School Mike Morgan, CSL Senior Vice President of Research Andrew Nash, University of Melbourne Vice-President (Enterprise) Doron Ben-Meir, COHR CEO & Director of Research Eric Reynolds, Member for Higgins Katie Allen and Brandon Capital Investment Manager Ingmar Wahlqvist at the launch of Denteric.

Bio21 Big Picture: 'Drug Discovery in the Ubiquitin Proteasome System' - 12pm, 22 October

Tuesday, 22 October, 2019 - 12:00 to 13:00

Hear Dr Larry Dick, Seofon Consulting, Natick, Massachusetts tell a 'Biotech to Big Pharma Journey.'

Media Release: A sweet solution for a persistent parasite

New research was published today [Cell Host and Microbe, 11 September] that shows how an important group of human pathogens cause disease, opening up fresh avenues for much needed therapies.

NHMRC funds Bio21 structural biology and drug development research

Congratulations to Bio21's Leann Tilley and David Ascher, who have received NHMRC Development and Investigator grants respectively.

New Microscope installed in Department of Biochemistry @Bio21

An exciting new microscope has been installed in the Biochemistry and Molecular Biology Node of the Biological Optical Microscopy Platform at the Bio21 Institute, 28 August 2019.

Pages

Subscribe to Bio21 Molecular Science & Biotechnology Institute RSS